|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4299 | Drugs / Medical | 05/27/2005
DES Daughters are defined as women born between 1938 and 1971 who were exposed to DES before birth (in the womb). Litigation has been ongoing for years on behalf of DES victims. Diethylstilbestrol (DES) is a synthetic estrogen that was developed to supplement a woman's natural estrogen production. First prescribed by physicians in 1938 for women who experienced miscarriages or premature deliveries, DES was originally considered effective and safe for both the pregnant woman and the developing baby.
In the United States, an estimated 5-10 million persons were exposed to DES during 1938-1971, including women who were prescribed DES while pregnant and the female and male children born of these pregnancies. In 1971, the Food and Drug Administration (FDA) issued a Drug Bulletin advising physicians to stop prescribing DES to pregnant women because it was linked to a rare vaginal cancer in female offspring. The Injuries and Their Impact 1. Clear cell adenocarcinoma of the vagina or cervix requiring hysterectomy or radiation 2. Uterine, cervical or tubal anomalies which cause: Primary infertility (never becoming pregnant) 3. Vaginal anomalies, which cause Constrictions or bands making intercourse difficult i. Multiple physician examinations and tests ii. Multiple cryosurgeries, biopsies and surgery 4. Third-generation injuries associated with preterm labor or delivery resulting in premature birth and cerebral palsy, blindness or other neurological deficits or death of child. 5. Infertility treatment due to infertility In vitro fertilization 6. Psychological injury: Depression Register your Manufacturers Des ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for Manufacturers Des, or click the red "submit" button on this page, and a lawyer will review your Manufacturers Des complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest An administrative proceeding has been filed against Smart Inventions, Inc., a California-based direct response TV company, and its Chief Operating Officer, Jon D. Nokes, by the Federal Trade Commission on behalf of persons who purchased “Biotape,” a tape-like substance promoted to treat or cure severe pain. The action alleges that there is no substantial evidence that the product relieves pain, and that the advertisements violate the FTC Act because they are false and misleading. Sutter Health settled a class-action lawsuit related to its billing of uninsured patients, under which the system agrees to abide by its charity-care policy, adopted in March 2006, for at least three more years. A class action has been filed against Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) and certain of its officers and directors by stockholders who purchased the company's common stock between March 27, 2000, and September 24, 2001. A class action has been filed against Yale New Haven Hospitals for failing to provide healthcare services to Connecticut residents regardless of their ability to pay. The lawsuit alleges that Yale has an obligation to provide free or low cost healthcare services because it operates as a non-profit organization and is exempt from federal, state and local taxes. Kahn Gauthier Swick is investigating possible legal actions against Boehringer Ingelheim Pharmaceuticals, Inc., the German pharmaceutical and chemical conglomerate, after it issued new warnings regarding its HIV drug Nevirapine (trade name Viramune) in February 2004. The new warnings indicate that the drug can cause severe, life-threatening toxicity in patients’ livers, possibly culminating in complete hepatic failure. These events are often associated with a rash that can sometimes become life-threatening in and of itself. If you or one of your loved ones has suffered such reactions or passed away due to one, please contact Kahn Gauthier for a consultation. A class action has been filed against Pfizer, Inc. and Mylan Laboratories, Inc. alleging that the two companies conspired to prevent the marketing of a generic version of the drug Procardia XL, thereby costing consumers money. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
